160 related articles for article (PubMed ID: 15488562)
1. PET imaging in assessing gastrointestinal tumors.
Hustinx R
Radiol Clin North Am; 2004 Nov; 42(6):1123-39, ix. PubMed ID: 15488562
[TBL] [Abstract][Full Text] [Related]
2. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Donswijk ML; Hess S; Mulders T; Lam MG
PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
[TBL] [Abstract][Full Text] [Related]
3. [[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Buchmann I; Ganten TM; Haberkorn U
Z Gastroenterol; 2008 Apr; 46(4):367-75. PubMed ID: 18393156
[TBL] [Abstract][Full Text] [Related]
4. [Role of positron emission tomography is the evaluation of digestive tract tumors].
Hustinx R; Paulus P; Daenen F; Detroz B; Honoré P; Jacquet N; Rigo P
Rev Med Liege; 1999 Dec; 54(12):925-30. PubMed ID: 10686798
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal malignancies evaluated with (18)F-fluoro-2-deoxyglucose positron emission tomography.
Chin BB; Chang PP
Best Pract Res Clin Gastroenterol; 2006 Feb; 20(1):3-21. PubMed ID: 16473798
[TBL] [Abstract][Full Text] [Related]
6. [Positron emission tomography (PET) in gastro-intestinal cancer].
Wartski M
Presse Med; 2016 Sep; 45(9):734-41. PubMed ID: 27542763
[TBL] [Abstract][Full Text] [Related]
7. Staging and follow-up of gastrointestinal tumors with PET/CT.
Rosenbaum SJ; Stergar H; Antoch G; Veit P; Bockisch A; Kühl H
Abdom Imaging; 2006; 31(1):25-35. PubMed ID: 16333707
[TBL] [Abstract][Full Text] [Related]
8. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
Junginger T; Kneist W; Schreckenberger M; Menzel C; Oberholzer K; Bartenstein P
Dtsch Med Wochenschr; 2002 Sep; 127(38):1935-41. PubMed ID: 12239652
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal tract malignancies and positron emission tomography: an overview.
Esteves FP; Schuster DM; Halkar RK
Semin Nucl Med; 2006 Apr; 36(2):169-81. PubMed ID: 16517238
[TBL] [Abstract][Full Text] [Related]
11. [Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)].
Bourguet P; Planchamp F; Monteil J; Metges JP; Mitry E; Tubiana-Mathieu N
Bull Cancer; 2007 Feb; 94(2):212-8. PubMed ID: 17338096
[No Abstract] [Full Text] [Related]
12. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
[TBL] [Abstract][Full Text] [Related]
13. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
[TBL] [Abstract][Full Text] [Related]
14. Role of positron emission tomography-computed tomography in gastrointestinal malignancies.
Banks KP; Song WS
Radiol Clin North Am; 2013 Sep; 51(5):799-831. PubMed ID: 24010907
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer.
Larson SM; Schoder H; Yeung H
Cancer J; 2004; 10(4):243-50. PubMed ID: 15383205
[TBL] [Abstract][Full Text] [Related]
16. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
17. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
Vrieze O; Haustermans K; De Wever W; Lerut T; Van Cutsem E; Ectors N; Hiele M; Flamen P
Radiother Oncol; 2004 Dec; 73(3):269-75. PubMed ID: 15588870
[TBL] [Abstract][Full Text] [Related]
18. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K
Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459
[TBL] [Abstract][Full Text] [Related]
19. Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms.
Gupta N; Bradfield H
Semin Nucl Med; 1996 Jan; 26(1):65-73. PubMed ID: 8623053
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography for the diagnosis and management of patients with gastrointestinal malignancies.
Saga T; Nakamoto Y; Higashi T; Yoshikawa K
Gastrointest Endosc Clin N Am; 2008 Jul; 18(3):479-93, ix. PubMed ID: 18674698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
